Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Tirzepatide is a once-weekly prescription medication that acts on two incretin hormone pathways—GIP and GLP-1 receptors—to help regulate appetite, blood sugar, and body weight. It works by increasing glucose-dependent insulin secretion, lowering glucagon, delaying gastric emptying, and reducing food intake; in practice, that means people often feel fuller sooner, eat less, and see improvements in blood sugar control and weight reduction. FDA labeling describes tirzepatide as a GIP receptor and GLP-1 receptor agonist.
Potential benefits of tirzepatide include lower blood sugar, reduced appetite, significant weight loss, improved insulin sensitivity, and lower calorie intake, with research and FDA materials also noting greater loss of fat mass than lean mass. Because it affects gut hormones and metabolism, it can also slow digestion and help reduce post-meal glucose spikes.
Tirzepatide is a once-weekly prescription medication that acts on two incretin hormone pathways—GIP and GLP-1 receptors—to help regulate appetite, blood sugar, and body weight. It works by increasing glucose-dependent insulin secretion, lowering glucagon, delaying gastric emptying, and reducing food intake; in practice, that means people often feel fuller sooner, eat less, and see improvements in blood sugar control and weight reduction. FDA labeling describes tirzepatide as a GIP receptor and GLP-1 receptor agonist.
Potential benefits of tirzepatide include lower blood sugar, reduced appetite, significant weight loss, improved insulin sensitivity, and lower calorie intake, with research and FDA materials also noting greater loss of fat mass than lean mass. Because it affects gut hormones and metabolism, it can also slow digestion and help reduce post-meal glucose spikes.